• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials.

作者信息

Cassese Salvatore, Ndrepepa Gjin, Fusaro Michele, Kufner Sebastian, Xhepa Erion, Fusaro Massimiliano

机构信息

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

出版信息

EuroIntervention. 2019 Aug 9;15(6):e560-e562. doi: 10.4244/EIJ-D-18-00550.

DOI:10.4244/EIJ-D-18-00550
PMID:30277463
Abstract
摘要

相似文献

1
Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials.药物涂层球囊血管成形术治疗股腘动脉疾病的紫杉醇密度与临床疗效：20项随机试验的荟萃分析及调整后的间接比较
EuroIntervention. 2019 Aug 9;15(6):e560-e562. doi: 10.4244/EIJ-D-18-00550.
2
Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).低剂量紫杉醇涂层与未涂层经皮腔内球囊血管成形术治疗股腘外周动脉疾病：ILLUMENATE欧洲随机临床试验（新型紫杉醇涂层经皮血管成形术球囊随机试验）的一年结果
Circulation. 2017 Jun 6;135(23):2227-2236. doi: 10.1161/CIRCULATIONAHA.116.026493. Epub 2017 Apr 19.
3
Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.用于股腘动脉疾病的紫杉醇涂层球囊
Curr Cardiol Rep. 2017 Feb;19(2):10. doi: 10.1007/s11886-017-0823-4.
4
Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison.紫杉醇涂层球囊或第一代裸镍钛合金支架用于股腘动脉血运重建：与未涂层球囊对比的随机试验荟萃分析及校正间接比较
Int J Cardiol. 2013 Oct 9;168(4):4002-9. doi: 10.1016/j.ijcard.2013.06.081. Epub 2013 Jul 23.
5
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.首例人体随机研究的 12 个月结果： Ranger 紫杉醇涂层球囊用于股腘治疗。
JACC Cardiovasc Interv. 2018 May 28;11(10):934-941. doi: 10.1016/j.jcin.2018.01.276. Epub 2018 May 2.
6
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄：PACUBA 试验 1 年结果。
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.
7
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.药物涂层球囊血管成形术与普通球囊血管成形术治疗股腘动脉疾病的系统评价和更新的荟萃分析。
J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21.
8
Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics.紫杉醇涂层球囊与标准未涂层球囊治疗糖尿病患者股腘长病变的比较。
Medicine (Baltimore). 2019 Mar;98(13):e14840. doi: 10.1097/MD.0000000000014840.
9
Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.雷杰紫杉醇涂层球囊在股腘段的初始随机研究的六个月结果。
J Endovasc Ther. 2017 Aug;24(4):459-467. doi: 10.1177/1526602817710770. Epub 2017 May 31.
10
Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.
JACC Cardiovasc Interv. 2018 Dec 10;11(23):2436-2438. doi: 10.1016/j.jcin.2018.07.029.

引用本文的文献

1
Chronic Kidney Disease Requiring Hemodialysis as a Significant Predictor of Target Lesion Revascularization After Endovascular Treatment of Femoropopliteal Occlusive Lesions with a Drug-Coated Balloon.需要血液透析的慢性肾脏病作为药物涂层球囊血管腔内治疗股腘动脉闭塞性病变后靶病变血管重建的重要预测因素
J Clin Med. 2025 Feb 22;14(5):1474. doi: 10.3390/jcm14051474.
2
Difference in one-year late lumen loss between high- and low-dose paclitaxel-coated balloons for femoropopliteal disease.股腘动脉病变中高剂量和低剂量紫杉醇涂层球囊一年后管腔丢失的差异。
Heart Vessels. 2024 Jul;39(7):582-588. doi: 10.1007/s00380-024-02370-0. Epub 2024 Feb 16.
3
Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
股腘动脉病变药物涂层球囊血管通畅率及其相关因素
J Am Heart Assoc. 2023 Jan 3;12(1):e025677. doi: 10.1161/JAHA.122.025677. Epub 2022 Dec 30.
4
Improvement of Outcome for Treatment of 'Restenosis-prone' Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries.“易发生再狭窄”血管病变治疗效果的改善？紫杉醇剂量对猪外周动脉晚期管腔丢失的潜在影响。
Cardiovasc Intervent Radiol. 2022 Dec;45(12):1822-1831. doi: 10.1007/s00270-022-03277-x. Epub 2022 Sep 15.
5
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials.紫杉醇涂层球囊血管成形术治疗股腘动脉疾病的获益与风险：一项随机对照试验的系统评价和荟萃分析
EClinicalMedicine. 2019 Oct 17;16:42-50. doi: 10.1016/j.eclinm.2019.09.004. eCollection 2019 Nov.